Author/Creator: Mackay, Fabienne - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Mackay, Fabienne

1. Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus. Issue 4 (21st April 2019)

Authors:: Vincent, Fabien B; Kandane‐Rathnayake, Rangi; Koelmeyer, Rachel; Hoi, Alberta Y; Harris, James; Mackay, Fabienne; Morand, Eric F
Journal:: Clinical & translational immunology
Issue:: Volume 8:Issue 4(2019)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus. Issue 1 (19th October 2018)

Authors:: Vincent, Fabien B; Slavin, Laura; Hoi, Alberta Y; Kitching, Arthur Richard; Mackay, Fabienne; Harris, James; Kandane-Rathnayake, Rangi; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 5:Issue 1(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Issue 2 (24th November 2012)

Authors:: Vincent, Fabien B; Morand, Eric F; Murphy, Kim; Mackay, Fabienne; Mariette, Xavier; Marcelli, Christian
Journal:: Annals of the rheumatic diseases
Issue:: Volume 72:Issue 2(2013)
Page Start:: 165
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation. Issue 1 (December 2017)

Authors:: Infantino, Simona; Light, Amanda; O'Donnell, Kristy; Bryant, Vanessa; Avery, Danielle; Elliott, Michael; Tangye, Stuart; Belz, Gabrielle; Mackay, Fabienne; Richard, Stephane; Tarlinton, David
Journal:: Nature communications
Issue:: Volume 8:Issue 1(2017)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020)

Authors:: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 7:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020)

Authors:: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 7:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020)

Authors:: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 7:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020)

Authors:: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 7:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020)

Authors:: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 7:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020)

Authors:: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F
Journal:: Lupus science & medicine
Issue:: Volume 7:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗